Peer Review reports
From: EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
| Original Submission | ||
|---|---|---|
| 14 Jun 2021 | Submitted | Original manuscript |
| 21 Jan 2022 | Author responded | Author comments - Stefan Gröschel |
| Resubmission - Version 2 | ||
| 21 Jan 2022 | Submitted | Manuscript version 2 |
| 7 Feb 2022 | Author responded | Author comments - Stefan Gröschel |
| Resubmission - Version 3 | ||
| 7 Feb 2022 | Submitted | Manuscript version 3 |
| 23 Feb 2022 | Author responded | Author comments - Stefan Gröschel |
| Resubmission - Version 4 | ||
| 23 Feb 2022 | Submitted | Manuscript version 4 |
| 22 Mar 2022 | Reviewed | Reviewer Report |
| 30 Mar 2022 | Reviewed | Reviewer Report |
| 1 Jul 2022 | Author responded | Author comments - Stefan Gröschel |
| Resubmission - Version 5 | ||
| 1 Jul 2022 | Submitted | Manuscript version 5 |
| 1 Jul 2022 | Author responded | Author comments - Stefan Gröschel |
| Resubmission - Version 6 | ||
| 1 Jul 2022 | Submitted | Manuscript version 6 |
| 1 Sep 2022 | Author responded | Author comments - Stefan Gröschel |
| Resubmission - Version 7 | ||
| 1 Sep 2022 | Submitted | Manuscript version 7 |
| 9 Sep 2022 | Author responded | Author comments - Stefan Gröschel |
| Resubmission - Version 8 | ||
| 9 Sep 2022 | Submitted | Manuscript version 8 |
| Publishing | ||
| 16 Sep 2022 | Editorially accepted | |
| 5 Oct 2022 | Article published | 10.1186/s12885-022-10109-1 |
You can find further information about peer review here.